Laura Clague, Chief Financial Officer at Travere Therapeutics, Inc. (RTRX), sold 7,500 shares at $22.72 ($175K) on 2020-11-25, disclosed to the SEC on 2020-11-25.
Open-market sale of $175k RTRX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.86 | 3,750 | $89K | 51.2% |
| 2 | $22.72 | 3,750 | $85K | 48.8% |
| Total | $23.29 avg | 7,500 | $175K | 100% |
| Filing → |
| TVTX | SELL | 2022-02-02 | $34K | — | Filing → |
| TVTX | SELL | 2022-01-26 | $103K | — | Filing → |
| TVTX | SELL | 2022-01-12 | $206K | — | Filing → |